| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070649 | European Journal of Surgical Oncology (EJSO) | 2005 | 6 Pages |
Abstract
Cytoreductive surgery combined with HIPEC is associated with an increased morbidity and mortality. Complications are predominantly related to major surgery. Following this aggressive treatment, survivors may achieve a satisfactory quality of life.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
U. Schmidt, M.H. Dahlke, J. Klempnauer, H.J. Schlitt, P. Piso,